In Brief This Week: Eurogentec; NuGen Technologies; Orchid Cellmark | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Eurogentec this week said that its Eurogentec North America subsidiary has received ISO 13485:2003 certification for the production and sale of oligonucleotides for the in vitro diagnostics market. The firm said that it is now the sole custom oligonucleotide contract manufacturing organization to be fully cGMP compliant and have ISO 13485 certified cleanroom sites in North America, Europe, and Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.